• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

InMode Is Back to Its Prior Low: What's Next for This Former High Flyer?

Let's look for clues on the stock charts.
By BRUCE KAMICH
Mar 20, 2020 | 01:13 PM EDT
Stocks quotes in this article: INMD

During the Mad Money program host Jim Cramer makes time for callers to ask about securities they are interested in. Thursday night one caller asked about InMode Ltd. (INMD) : "I like this one. This is in the sweet spot," said Cramer.

InMode makes a skin rejuvenation device I could use about now, but let's look at the charts first.

In the daily candlestick chart of INMD, below, we can see prices had an initial rally into a November high followed by two declines bringing prices back down to around their IPO price. Prices are below the declining 20-day and 50-day moving average lines.

The On-Balance-Volume (OBV) line is pointed down telling us that sellers of INMD have been more aggressive. The 12-day price momentum study is showing lower lows, which tells us that the pace of the recent decline has not yet slowed down. Prices could be making a low now but I am not getting any positive clues to support that theory.

In this Point and Figure chart of INMD, below, we can see that prices have reached and exceeded the downside price target of $37. There are no signs yet of accumulation.

Bottom-line strategy: There is a saying that if you don't attack you will never earn a Navy Cross, but if you don't see a base pattern you probably won't buy a stock too soon. I would wait before buying INMD.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Mad Money

More from Stocks

Why I Would Be a Buyer of United Microelectronics

Bruce Kamich
May 26, 2022 1:14 PM EDT

Take a look at this chipmaker's charts.

Investing in Fantasyland Will Only Earn You Fantasies

Jim Collins
May 26, 2022 12:25 PM EDT

Here are the areas I'm buying, and here and the areas of which I'm turning away in disgust.

How I'm Approaching Stocks and Bonds After the Fed Minutes

Peter Tchir
May 26, 2022 12:19 PM EDT

I see three key takeaways from Wednesday's FOMC release.

The Bounce Is On: Here's What I've Been Buying

James "Rev Shark" DePorre
May 26, 2022 11:28 AM EDT

The big question now is how far can this run?

Is Lululemon About to Stage a Recovery?

Bruce Kamich
May 26, 2022 10:47 AM EDT

With the stock almost cut in half in the past six months the right conditions may be in place for a rally.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login